<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>revista-medicina-scolara</PublisherName>
      <JournalTitle>The Journal of School and University Medicine</JournalTitle>
      <PISSN/>
      <EISSN/>
      <Volume-Issue/>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season/>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical</ArticleType>
      <ArticleTitle>MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED SARS-CoV-2, A NOVEL SPECTRUM OF PEDIATRIC ILNESS
</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>0</FirstPage>
      <LastPage>0</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Bianca</FirstName>
          <LastName>Huluban</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Multisystem inflammatory syndrome temporally associated with COVID-19 (MIS-C) has been described as a novel and often severe presentation of SARS-CoV-2 infection in children.

This syndrome is characterized by fever, abdominal pain, gastrointestinal and cutaneous symptoms, and hemodynamic alterations. MIS-C has similar features to those of Kawasaki disease (KD), toxic shock syndrome (TSS), macrophage-activation syndrome, bacterial sepsis, meningitis. 

MIS-C is typically a progressive illness, and patients who initially had mild symptoms can develop severe illness with multi-organ dysfunction within a few days of symptom onset.

The majority of affected children were treated with intravenous immune globulin (IVIG), and several also received adjunctive high-dose steroids.

The paediatricians should be aware about this new and potentially life threatening condition in children during COVID-19 epidemics</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Covid 19, Multisystemic inflammatory syndrome, children</Keywords>
      <URLs>
        <Abstract>https://revista-medicina-scolara.ro/ubijournal-v1copy/journals/abstract.php?article_id=9684&amp;title=MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED SARS-CoV-2, A NOVEL SPECTRUM OF PEDIATRIC ILNESS</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References/>
      </References>
    </Journal>
  </Article>
</ArticleSet>